Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.
Rapidly growing tumor cells require a nutrient-rich environment in order to thrive, therefore, restricting access to certain key amino acids, such as arginine, often results in the death of malignant cells, which frequently display defective cell cycle check-point control. Healthy cells, by contrast...
Guardado en:
Autores principales: | James W Wells, Christopher H Evans, Milcah C Scott, Barbara C Rütgen, Timothy D O'Brien, Jaime F Modiano, Goran Cvetkovic, Slobodan Tepic |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6d0e88b6c8394e96a192ccd3dd287118 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Arginine deprivation therapy for malignant melanoma
por: Yoon JK, et al.
Publicado: (2012) -
Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment
por: Takuya Mizuno, et al.
Publicado: (2020) -
Natural Killer and T Cell Infiltration in Canine Osteosarcoma: Clinical Implications and Translational Relevance
por: Aryana M. Razmara, et al.
Publicado: (2021) -
Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer.
por: Philippe O Gannon, et al.
Publicado: (2010) -
Suppression of vascular endothelial growth factor expression by cannabinoids in a canine osteosarcoma cell line
por: Figueiredo AS, et al.
Publicado: (2013)